Latest Roche Diagnostics Stories
GIA announces the release of a comprehensive global report on Genetic Testing markets.
The molecular diagnostics market is categorized on the basis of application, technology, end user, product, and geography.
ReportsnReports.com adds “Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories),
DALLAS, June 17, 2014 /PRNewswire/ -- According to new Market Research Report "Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology),
The global point-of-care diagnostics market is dominated by North America, followed by Europe, Asia-Pacific and the Rest of the World (RoW) -
LONDON, June 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LAVAL, QC, June 10, 2014 /CNW Telbec/ - Roche announced that Health Canada approved the cobas® 4800 HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical
PORTLAND, Oregon, June 10, 2014 /PRNewswire/ -- According to a new research report by Allied Market Research titled "Global Companion Diagnostic Market (Indications, Technologies
Market Size - $4,476.6 mn in 2013, Market Growth - CAGR of 8.7%, Market Trends - High demand for personalized medicine & genetic testing.
Tissue diagnostics are an important set of techniques, primarily used for the diagnosis, monitoring and management of cancer.
- A political dynamiter.